04.19.21 -- How To Navigate Compliance With FDA's 21 CFR Part 11
04.19.21 -- How To Navigate Compliance With FDA's 21 CFR Part 11 CUE Biopharma CEO Dan Passeri, JD joins the Business of Biotech to discuss the development of their Immuno-STAT platform for the selective targeting and alteration of T cells. Passeri shares how the CUE-100 series of candidates in its pipeline are being developed to address a scourge of HPV-related head, neck, and other cancers. Listen now and subscribe so you never miss an episode. Featured Editorial By Kyle Neuman, SAFE Identity 21 CFR Part 11, the FDA's regulation on electronic records an...
Source: clinicalleader.com